Trial intelligence / Profile preview

Fomepizole mixed-meal study of microbially produced ethanol in NASH

NL-OMON20655Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Trial of fomepizole in metabolic dysfunction-associated steatohepatitis (MASH) (2 arms), sponsored by Amsterdam University Medical Center. Started Apr 2019; status: active, not recruiting.

02

Drugs

fomepizole
03

Conditions

metabolic dysfunction-associated steatohepatitis (MASH)

Beyond the preview

Go deeper on NL-OMON20655.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20655.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call